At MedFuse, we’re particularly excited about initiatives like our new impressions metric . . .

 Listen in and discover more 

Younger generations are encountering health challenges even earlier than the generations ahead of them . . . 

Take a deep dive into the most buzzed-about prescription drugs to better understand key healthcare markets and how new segments are contributing to their growth . . .

Trends in healthcare utilization reflect the evolving dynamics of patient interactions and procedures . . .

Turning our attention to prescribing trends, a consistent pattern has emerged over time . . . 

A significant flaw has developed within healthcare marketing . . . 

An innate connection exists between the quality of data and the caliber of strategic decisions . . .

Friday, April 21, 2023 Industry Veteran Fred Schembri Joins MedFuse as Chief Commercial Officer. MedFuse is pleased to announce the appointment of Fred Schembri as Chief Commercial Officer, assuming responsibility for...

People have more prescription medications as they get older. This is not a new insight, but rather an intuitive one . . .

NEW YORK, July 13, 2022 /PRNewswire/ -- DeepIntent, the leading healthcare advertising technology company built to influence better patient health and business outcomes, today announced the addition of audience segments from Redi-Data, MedFuse . . .

US healthcare has experienced significant changes over the past few years. Predicting the future has been like guessing which direction a bucket of superballs will bounce when poured out. The good news is, we have claims data . . .

Telehealth looks to be heading in the same direction as Billy Bean’s career. Not the Money Ball general manager who innovated the use of data and analytics to maximize on-field success, but Billy Bean the great baseball player prospect who never fulfilled expectations...

At times success can be difficult to recognize and how you define success has a major impact on the decisions you make...